Alpha 2.0
Login Register
» Authors » Yukari Mitsui

Yukari Mitsui

Explore the profile of Yukari Mitsui including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 23
Followers 0
Related Specialties
Endocrinology
General Medicine
Biomedical Engineering
Top 10 Co-Authors
Itsuro Endo
Masahiro Abe
Kiyoe Kurahashi
Ken-Ichi Aihara
Shiho Masuda
Akio Kuroda
Munehide Matsuhisa
Tomoyo Hara
Sumiko Yoshida
Hiroki Yamagami
Published In
J Diabetes Investig
J Atheroscler Thromb
Biomedicines
JBMR Plus
Heliyon
Affiliations
Soon will be listed here.
Recent Articles
1.
Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes
Hara T, Watanabe T, Yamagami H, Miyataka K, Yasui S, Asai T, et al.
Biomedicines . 2024 Aug; 12(8). PMID: 39200252
Although hyperglycemia and hypertension are well-known risk factors for glomerular injury in individuals with type 2 diabetes (T2D), specific risk factors for tubular injury remain unclear. We aimed to clarify...
2.
Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1
Kanai M, Ganbaatar B, Endo I, Ohnishi Y, Teramachi J, Tenshin H, et al.
Int J Mol Sci . 2024 Jun; 25(11). PMID: 38891908
Chronic inflammation causes muscle wasting. Because most inflammatory cytokine signals are mediated via TGF-β-activated kinase-1 (TAK1) activation, inflammatory cytokine-induced muscle wasting may be ameliorated by the inhibition of TAK1 activity....
3.
Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011-2020) in Individuals with and without Diabetes at a Japanese Community General Hospital
Hosoki M, Hori T, Kaneko Y, Mori K, Yasui S, Tsuji S, et al.
J Clin Med . 2024 Apr; 13(5). PMID: 38592103
Since diabetes and its complications have been thought to exaggerate cardiorenal disease, resulting in a short lifespan, we investigated causes of death and lifespans in individuals with and without diabetes...
4.
Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes
Yamagami H, Hara T, Yasui S, Hosoki M, Hori T, Kaneko Y, et al.
Biomedicines . 2023 Nov; 11(11). PMID: 38002020
It has previously been unclear whether the accumulation of advanced glycation end products, which can be measured using skin autofluorescence (SAF), has a significant role in diabetic kidney disease (DKD),...
5.
Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis
Masuda S, Hara T, Yamagami H, Mitsui Y, Kurahashi K, Yoshida S, et al.
J Atheroscler Thromb . 2023 Apr; 30(11):1727-1741. PMID: 37081616
Aims: It is known that there are sex differences in vascular endothelial function and the development of chronic kidney diseases; however, it remains unclear whether sex differences influence the association...
6.
Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes
Hori T, Nakamura S, Yamagami H, Yasui S, Hosoki M, Hara T, et al.
Heliyon . 2023 Apr; 9(4):e14724. PMID: 37057050
Background: Anemia is one of the common complications of diabetes and is associated with mortality. Phase angle (PhA), ratio of extracellular water to total body water (ECW/TBW) and skeletal muscle...
7.
An attempt to create a treatment algorithm of central adrenal insufficiency using CRH test, DHEA-S and clinical evaluation
Mitsui Y, Iizuka Y, Tanaka T, Hara T, Masuda S, Ohnishi Y, et al.
J Med Invest . 2022 Oct; 69(3.4):287-293. PMID: 36244782
Objective : To examine diagnostic performance of corticotropin-releasing hormone (CRH) test combined with baseline dehydroepiandrosterone sulfate (DHEA-S) in patients with a suspect of central adrenal insufficiency. Methods : Patients (n=215)...
8.
Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
Hara T, Uemoto R, Sekine A, Mitsui Y, Masuda S, Yamagami H, et al.
J Atheroscler Thromb . 2022 Oct; 30(8):871-883. PMID: 36244745
Aims: Thrombin exerts various pathophysiological functions by activating protease-activated receptors (PARs), and thrombin-induced activation of PARs promotes the development of non-alcoholic fatty liver disease (NAFLD). Since heparin cofactor II (HCII)...
9.
Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNA
Okada A, Yamada-Yamashita M, Tominaga Y, Jo K, Mori H, Suzuki R, et al.
J Diabetes Investig . 2022 Apr; 13(7):1140-1148. PMID: 35396829
Aims/introduction: Several research groups have reported methods for quantifying pancreatic beta cell (β-cell) injury by measuring β-cell-specific CpG unmethylation of the insulin gene in circulation using digital droplet PCR or...
10.
Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes
Hara T, Uemoto R, Sekine A, Mitsui Y, Masuda S, Kurahashi K, et al.
J Diabetes Investig . 2021 May; 12(12):2172-2182. PMID: 34043882
Aims/introduction: Thrombin exerts various pathophysiological functions by activating protease-activated receptors (PARs). Recent data have shown that PARs influence the development of glomerular diseases including diabetic kidney disease (DKD) by regulating...